Reusable syringe market projected to hit $3.34 billion by 2030

The reusable syringe market is forecast to grow from $2.24 billion in 2025 to $3.34 billion by 2030, driven by waste-reduction goals, sustainability efforts and broader adoption in healthcare and lab settings. North America leads today, while Asia-Pacific is expected to grow fastest.

Why it matters: - Reusable syringes offer healthcare providers a way to cut operating costs over time while reducing medical waste. - The market’s projected 8.3% compound annual growth rate through 2030 points to rising demand for lower-waste medical devices. - Sustainability pressures and tighter waste rules are pushing healthcare systems toward reusable injection tools.

What happened: - The reusable syringe market is forecast to rise from $2.24 billion in 2025 to $2.43 billion in 2026. - The market is projected to reach $3.34 billion by 2030. - The forecast implies an 8.1% CAGR from 2025 to 2026 and an 8.3% CAGR from 2025 to 2030. - The Business Research Company released the market outlook on July 21, 2026. - Download a free sample of the report.

The details: - Reusable syringes are designed to be sterilized and used multiple times, unlike disposable syringes that are discarded after one use. - The devices typically use durable barrels, plungers and needles made from glass or metal. - The market’s recent growth has been supported by rising healthcare spending, wider use of reusable medical tools, efforts to cut medical waste, broader vaccination initiatives and the cost advantages of multi-use devices. - Future growth is expected to be driven by more resilient syringe materials, stronger demand for sustainable healthcare products, adoption in emerging healthcare markets, expansion of research and diagnostic labs, and better sterilization and infection-control infrastructure. - Expected trends include longer-life sterilizable materials, more use in cost-sensitive healthcare settings, more safety-engineered reusable designs, broader veterinary and laboratory applications, and continued emphasis on reducing medical waste. - View the full report.

Between the lines: - The market story is not just about cost. It also reflects a broader shift toward sustainability in healthcare procurement and operations. - Environmental policy appears to be a key demand driver as providers look for ways to reduce single-use plastic waste. - UK healthcare providers generated about 156,000 tonnes of clinical waste annually, according to NHS Digital data cited from March 2023, underscoring the scale of the waste problem. - That volume was compared with more than 400 fully loaded jumbo jets, highlighting the pressure on health systems to find lower-waste alternatives. - North America was the largest regional market in 2025, supported by established healthcare infrastructure and environmental regulations. - Asia-Pacific is expected to post the fastest growth during the forecast period as healthcare access expands and medical infrastructure investment rises. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

What's next: - The market is expected to keep expanding as healthcare systems invest in sterilization and infection-control infrastructure. - Adoption should broaden in veterinary and laboratory settings as reusable designs become more specialized. - The 2026 report edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated technology and trend analysis. - The Business Research Company says it offers more than 30,000 reports across 27 industries and 60 geographies, supported by 1,500,000 datasets and its Global Market Model platform.

The bottom line: - Reusable syringes are moving from niche cost-saving tools to a growth market shaped by sustainability, regulation and healthcare efficiency.